Abstract
Introduction: The Upper Limb Performance Analysis
(ULPA), an emerging client-centred upper limb (UL) assessment, has demonstrated validity and capacity to demonstrate change using standardised tasks. However, standardised tasks do not reflect personally meaningful occupational performance and may not be well aligned with a client’s abilities. In spasticity management, Goal Attainment Scaling (GAS) is a demonstrated measure of goal achievement; however, it does not record specific functional UL movement changes contributing to or limiting goal achievement.
Objectives: This study aimed to evaluate the capacity of the Comparative Analysis of Performance -Motor (CAPM) (an ULPA sub-stage) to measure UL performance change of self-selected spasticity-related goals after botulinum toxin A for adults with acquired upper motor neuron syndromes.
Method/Approach: This study’s approach was pre/post study evaluating UL performance using the GAS for each goal alongside the three CAP-M sub-categories (Observed, Excessive and Missing movements). Change in UL performance, relationships between CAP-M scores
and goal achievement were identified.
Results/Practice implications: A total of 42 selfselected goals set by 25 adults were analysed. Significant change (p < 0.001) in UL performance was evident postinjection for all CAP-M sub-stages: observed movement (pre = 32%; post = 54%;t = 6.1), excessive movement (Pre = 67%;Post = 46%; t = 6.7) and missing movement (pre = 47%;post = 35%;t = 4.0). A reduction in the number of missing movements post-injection correlated with goal achievement (rs = 0.36, p = 0.019), indicating that increased ability to perform required task movements was associated with goal attainment. Differences in UL change for achievement of active/passive goals were also evident.
Conclusion: ULPA CAP-M has demonstrated capacity to measure UL performance of person-centred goals, providing a unique perspective for rehabilitation clinical practice and research.
(ULPA), an emerging client-centred upper limb (UL) assessment, has demonstrated validity and capacity to demonstrate change using standardised tasks. However, standardised tasks do not reflect personally meaningful occupational performance and may not be well aligned with a client’s abilities. In spasticity management, Goal Attainment Scaling (GAS) is a demonstrated measure of goal achievement; however, it does not record specific functional UL movement changes contributing to or limiting goal achievement.
Objectives: This study aimed to evaluate the capacity of the Comparative Analysis of Performance -Motor (CAPM) (an ULPA sub-stage) to measure UL performance change of self-selected spasticity-related goals after botulinum toxin A for adults with acquired upper motor neuron syndromes.
Method/Approach: This study’s approach was pre/post study evaluating UL performance using the GAS for each goal alongside the three CAP-M sub-categories (Observed, Excessive and Missing movements). Change in UL performance, relationships between CAP-M scores
and goal achievement were identified.
Results/Practice implications: A total of 42 selfselected goals set by 25 adults were analysed. Significant change (p < 0.001) in UL performance was evident postinjection for all CAP-M sub-stages: observed movement (pre = 32%; post = 54%;t = 6.1), excessive movement (Pre = 67%;Post = 46%; t = 6.7) and missing movement (pre = 47%;post = 35%;t = 4.0). A reduction in the number of missing movements post-injection correlated with goal achievement (rs = 0.36, p = 0.019), indicating that increased ability to perform required task movements was associated with goal attainment. Differences in UL change for achievement of active/passive goals were also evident.
Conclusion: ULPA CAP-M has demonstrated capacity to measure UL performance of person-centred goals, providing a unique perspective for rehabilitation clinical practice and research.
| Original language | English |
|---|---|
| Pages | 159 |
| Number of pages | 1 |
| DOIs | |
| Publication status | Published - 19 Jun 2023 |
| Event | Occupational Therapy Australia 30th National Conference and Exhibition 2023 - Cairns Convention Centre, Cairns, Australia Duration: 21 Jun 2023 → 23 Jun 2023 https://otaus.com.au/news/otaus2023-wrap-up https://onlinelibrary.wiley.com/toc/14401630/2023/70/S1 (Proceedings) |
Conference
| Conference | Occupational Therapy Australia 30th National Conference and Exhibition 2023 |
|---|---|
| Abbreviated title | Ignite your passion |
| Country/Territory | Australia |
| City | Cairns |
| Period | 21/06/23 → 23/06/23 |
| Other | OTA was excited to welcome delegates to Cairns Convention Centre for our 30th National Conference & Exhibition (OTAUS2023) on 21 - 23 June. The conference represents the pinnacle of Australian OT excellence, showcasing opportunities, innovations and strategies informed through research and practice that can shape future practices, policies and educational approaches to facilitate the growth of occupational wellbeing worldwide. |
| Internet address |